Navigation Links
Ondine Announces Publication of Positive Results from Pseudomonas aeruginosa Eradication Study
Date:8/7/2008

se antibiotics today. Our recent publication highlights the rigorous approach we take to research and development, and adds to the peer-reviewed literature available to our potential strategic partners for additional photodisinfection indications."

About Ondine Biopharma Corporation

Ondine is developing non-antibiotic therapies for the treatment of a broad spectrum of bacterial, fungal and viral infections. The Company is focused on developing and commercializing leading edge products utilizing its patented light-activated technology. Photodisinfection provides broad-spectrum antimicrobial efficacy without encouraging the formation and spread of antibiotic resistance. The Company is based in Vancouver, British Columbia, Canada, with a research laboratory in Bothell, Washington, and an international office in St Michael, Barbados. For additional information, please visit the Company's website at: http://www.ondinebiopharma.com

Forward-Looking Statements:

Certain statements contained in this release containing words like "believe", "intend", "may", "expect" and other similar expressions, are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the Company's forward-looking statements include the following: market acceptance of our technologies and products; our ability to obtain financing; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain and develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key products and other risk factors identified from time to time in
'/>"/>

SOURCE Ondine Biopharma Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Ondine to Present at Canaccord Adams 28th Annual Global Growth Conference
2. Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights
3. GeneNews Announces Second Quarter Results
4. deCODE genetics Announces Second Quarter 2008 Financial Results
5. Interleukin Genetics Announces Conference Call and Webcast to Discuss Second Quarter 2008 Business Results
6. NxStage Announces Investor Conference Schedule
7. Pressure BioSciences, Inc. Announces the Market Release of its PCT-Enhanced Trypsin Digestion Application for Proteomics
8. China Pharma Holdings, Inc. Announces Second Quarter 2008 Financial Results
9. Ortho Biotech Announces Nationwide Voluntary Recall of Procrit(R) (Epoetin Alfa) Lot Number P114942A
10. Arbios Announces It Has Suspended Operations
11. PolyOne Corporation Announces an Exclusive License Agreement with Battelle for Bio-Plasticizer Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... N.Y. , June 18, 2013  AMRI ... its Burlington, Mass. , site ... Drug Enforcement Administration (DEA) registration to handle Schedule ... the DEA,s acknowledgement of Burlington,s ... control and documentation. (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ...
(Date:6/18/2013)... 2013 This webinar will examine ... and promotion, and review the basic FDA regulations ... to apply these principles through real world case ...     The fundamentals on FDA regulations and guidance related ...     Assessing traditional and newer forms of promotional ...
(Date:6/18/2013)... June 18, 2013 As a ... Inc proudly announces the release of their infographic ... Fitness ". , MeMD's goal was to leverage ... of Health 2.0, Health 3.0 and mHealth.The infographic ... transform medical care and the fitness industry in ...
(Date:6/18/2013)... Minneapolis, MN (PRWEB) June 18, 2013 ... the Saniclave 200 prevent the dangers of ... confusing features, like knobs, analog pressure gauges, hot surfaces ... older autoclave, or a new, modern autoclave, Revolutionary Science ... use fresh water. Older autoclave designs will recycle ...
Breaking Biology Technology:AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2How to Autoclave: Why the User Friendliness of the Saniclave 200 is So Important Today 2
... Neogen Corporation (NASDAQ: NEOG ) announced today ... seafood testing laboratory from its parent company, GlycoMar Ltd. ... services to the shellfish and salmon aquaculture industries. VeroMara,s ... including E. coli , noroviruses, and salmon husbandry. ...
... 2011 , Kuros Biosurgery AG, ... biomaterials and bioactive-biomaterial,combination products for trauma, wound and ... Application,00910049 by the European Patent Office. This now ... broad portfolio of applications,and patents designed to protect ...
... TRIANGLE PARK, N.C., June 17, 2011 Max ... the prestigious Max Group whose sister-company, Max Healthcare ... of Minimal Access, Metabolic & Bariatric Surgery, accredited ... Surgical Review Corporation (SRC), USA.  The institute has ...
Cached Biology Technology:Neogen Acquires VeroMara from GlycoMar Ltd. 2Kuros Announces Allowance of European Patent for Synthetic Biomaterials 2Kuros Announces Allowance of European Patent for Synthetic Biomaterials 3Max Institute of Minimal Access, Metabolic & Bariatric Surgery Accredited as an International Centre of Excellence for Minimal Invasive Surgery 2
(Date:6/18/2013)... New research from the University of Adelaide shows that ... a baby,s life is linked to a higher IQ at early ... Public Health researchers, who analysed data from more than 13,800 children ... Pediatrics , show that babies who put on ... IQ 1.5 points higher by the time they were six years ...
(Date:6/17/2013)... Researchers have identified a new virus in patients with ... to determine whether the virus is responsible for the ... a total of 28 out of 644 patients with ... 4%, but not in any of the 122 patients ... of the brain and central nervous system are often ...
(Date:6/17/2013)... June 6, professors in Wayne State University,s Department ... Foundation-funded (NSF) Research Experience for Undergraduates (REU) program. ... to do cutting-edge research in astrophysics, and in ... Alexey Petrov, Ph.D., professor of physics in Wayne ... and program director of the grant, the student ...
Breaking Biology News(10 mins):IQ link to baby's weight gain in first month 2New virus isolated from patients with severe brain infections 2New virus isolated from patients with severe brain infections 3Wayne State welcomes undergraduates from around the US for physics research experience 2
... certain enzyme can resist the normal effects of a heart ... and still-oxygenated heart tissue, according to a study by researchers ... the possibility of a therapy that could stimulate the growth ... as well as prevent an attack from occurring at all, ...
... Researchers at the Department of Energy,s Oak Ridge National ... at how developing nerve cells may hold a key ... and Parkinson,s disease. St. Jude scientists have linked ... the brains and retinas of young mice to certain ...
... damage can be triggered by various insults, including hepatitis ... can lead to cancer. A new study by researchers ... reveals how one protein helps decide the fate of ... online on March 30th in the Journal of ...
Cached Biology News:A missing enzyme conveys major heart protection in pre-clinical work 2A missing enzyme conveys major heart protection in pre-clinical work 3ORNL, St. Jude track neurons to predict and prevent disease 2
... peptide derived from the C-terminal region of ... D iris-expressed growth factor spinal cord-derived growth ... rat by one amino acid replacement. ... mouse and rat PDGF-D proteins. Reactivity: ...
Antibodies were affinity purified using epitopes specific to USP33 immobilized on solid support....
...
... 100% ,human IgG subclass 2 ... 100% ,human IgG subclass 4 ... 100% ,human IgG Fc ... IgG Fab ...
Biology Products: